Fluorometholone Study
Part of paid clinical trials in Pittsburgh, Pennsylvania.
- Sponsor
- Vishal Jhanji
- Study ID
- NCT07308938
- Phase
- PHASE2
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Corneal Ulcer (Diagnosis)
- Keratitis Bacterial
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Adjunctive Topical Fluorometholone (FML) 0.1% — DRUGAdjunctive Topical Fluorometholone (FML) 0.1% will be used
- Standard Topical Antibiotic Therapy — DRUGPatients will be treated with antibiotics (Cefazolin, Tobramycin or Moxifloxacin) we per treating physician
Study Details
The investigators seek to determine whether adjunctive topical fluorometholone (FML) improves best-corrected visual acuity (BCVA) at 3 months in patients with bacterial corneal ulcers compared with standard topical antibiotic therapy alone.
Key Dates
- Start date
- Oct 31, 2026
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2029
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 174 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Intervention ArmStandard Topical Antibiotic Therapy + Fluorometholone
- Active Comparator: Control ArmStandard Topical Antibiotic Therapy Alone
Primary Outcome Measure
Best Corrected Visual Acuity (BCVA) [ Time Frame: From enrollment to 3 months ]
Central Contacts
- Rose Carla Aubourg, BA412-642-7888
- Sarah Waters412-642-7888
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UPMC Vision Institute | Pittsburgh | Pennsylvania | 15219 | Vishal Jhanji, MD (PRINCIPAL_INVESTIGATOR) Alex Mammen, MD (SUB_INVESTIGATOR) Sabrina Mukhtar, MD (SUB_INVESTIGATOR) Prakash Gaurav, MD (SUB_INVESTIGATOR) |
Find similar trials in Pittsburgh, PA
By research site